BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 1650804)

  • 1. Hypothalamic and suprahypothalamic effects of prolonged treatment with dexamethasone in the rat.
    Calogero AE; Liapi C; Chrousos GP
    J Endocrinol Invest; 1991 Apr; 14(4):277-86. PubMed ID: 1650804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple feedback regulatory loops upon rat hypothalamic corticotropin-releasing hormone secretion. Potential clinical implications.
    Calogero AE; Gallucci WT; Gold PW; Chrousos GP
    J Clin Invest; 1988 Sep; 82(3):767-74. PubMed ID: 2843570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery of the rat hypothalamic-pituitary-adrenal axis after discontinuation of prolonged treatment with the synthetic glucocorticoid agonist dexamethasone.
    Calogero AE; Kamilaris TC; Johnson EO; Tartaglia ME; Chrousos G
    Endocrinology; 1990 Oct; 127(4):1574-9. PubMed ID: 2169393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotropin secretagogues facilitate recovery of the hypothalamus-pituitary-adrenal axis suppressed by prolonged treatment with dexamethasone.
    Huang TS
    Metabolism; 1994 May; 43(5):544-8. PubMed ID: 8177041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant infusion of ovine corticotropin-releasing hormone does not prevent suppression of the hypothalamus-pituitary-adrenal axis by dexamethasone in male rats.
    Huang TS
    J Endocrinol Invest; 1997; 20(7):393-6. PubMed ID: 9309537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro effects of arginine-vasopressin receptor antagonists on the hypothalamic-pituitary-adrenal axis in the rat.
    Bernardini R; Chiarenza A; Kamilaris TC; Renaud N; Lempereur L; Demitrack M; Gold PW; Chrousos GP
    Neuroendocrinology; 1994 Nov; 60(5):503-8. PubMed ID: 7845540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action.
    Spinedi E; Giacomini M; Jacquier MC; Gaillard RC
    Neuroendocrinology; 1991 Feb; 53(2):160-70. PubMed ID: 1849620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-lasting deficient dexamethasone suppression of hypothalamic-pituitary-adrenocortical activation following peripheral CRF challenge in socially defeated rats.
    Buwalda B; de Boer SF; Schmidt ED; Felszeghy K; Nyakas C; Sgoifo A; Van der Vegt BJ; Tilders FJ; Bohus B; Koolhaas JM
    J Neuroendocrinol; 1999 Jul; 11(7):513-20. PubMed ID: 10444308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal exposure to dexamethasone alters hippocampal drive on hypothalamic-pituitary-adrenal axis activity in adult male rats.
    Shoener JA; Baig R; Page KC
    Am J Physiol Regul Integr Comp Physiol; 2006 May; 290(5):R1366-73. PubMed ID: 16397092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
    Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
    J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced glucocorticoid feedback inhibition of hypothalamo-pituitary-adrenal responses to stress in adult rats neonatally treated with dexamethasone.
    Kamphuis PJ; Bakker JM; Broekhoven MH; Kunne C; Croiset G; Lentjes EG; Tilders FJ; van Bel F; Wiegant VM
    Neuroendocrinology; 2002 Sep; 76(3):158-69. PubMed ID: 12218348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin stimulates rat hypothalamic corticotropin-releasing hormone and pituitary adrenocorticotropin secretion in vitro.
    Weber RF; Calogero AE
    Neuroendocrinology; 1991 Sep; 54(3):248-53. PubMed ID: 1658672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
    van Haarst AD; Oitzl MS; Workel JO; de Kloet ER
    Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desensitization of the hypothalamic-pituitary-adrenal axis following prolonged administration of corticotropin-releasing hormone or vasopressin.
    Tizabi Y; Aguilera G
    Neuroendocrinology; 1992 Nov; 56(5):611-8. PubMed ID: 1336816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotransmitter-induced hypothalamic-pituitary-adrenal axis responsiveness is defective in inflammatory disease-susceptible Lewis rats: in vivo and in vitro studies suggesting globally defective hypothalamic secretion of corticotropin-releasing hormone.
    Calogero AE; Sternberg EM; Bagdy G; Smith C; Bernardini R; Aksentijevich S; Wilder RL; Gold PW; Chrousos GP
    Neuroendocrinology; 1992 May; 55(5):600-8. PubMed ID: 1350069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenalectomy and experimental hypercorticalism modulate the basal, corticotropin-releasing-hormone- and arginine-vasopressin-stimulated release of hypothalamic beta-endorphin.
    Patchev VK; Racké K; Almeida OF
    Neuroendocrinology; 1991 Aug; 54(2):111-7. PubMed ID: 1766548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of type I and II corticosteroid receptors in regulation of basal activity in the hypothalamo-pituitary-adrenal axis during the diurnal trough and the peak: evidence for a nonadditive effect of combined receptor occupation.
    Bradbury MJ; Akana SF; Dallman MF
    Endocrinology; 1994 Mar; 134(3):1286-96. PubMed ID: 8119168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasopressin and CRF-ACTH in adrenalectomized and dexamethasone-treated rats.
    Hashimoto K; Yunoki S; Kageyama J; Ohno N; Takahara J; Ofuji T
    Neuroendocrinology; 1981 Feb; 32(2):87-91. PubMed ID: 6259547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antenatal glucocorticoids blunt the functioning of the hypothalamic-pituitary-adrenal axis of neonates and disturb some behaviors in juveniles.
    Burlet G; Fernette B; Blanchard S; Angel E; Tankosic P; Maccari S; Burlet A
    Neuroscience; 2005; 133(1):221-30. PubMed ID: 15893645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
    J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.